Primary membranous nephropathy is a type of kidney disease that affects the natural filtration process, resulting in excess protein output. When left untreated, kidney failure may develop.

Obesity is an important health issue for patients with chronic kidney disease, speeding its progression, contributing to ...

About one-third of adults with diabetes have kidney disease. Without management, high blood sugar can damage your kidneys. The damage can worsen over time. Diabetic nephropathy, or kidney damage ...

Diabetic nephropathy is the leading cause of kidney disease in patients starting renal replacement therapy and affects ~40% of type 1 and type 2 diabetic patients. It increases the risk of death ...

Annual health checkups regularly include urine tests that serve several purposes, including checking for symptoms of kidney ...

Atrasentan hydrochloride is under clinical development by Novartis and currently in Phase II for Kidney Disease (Nephropathy).

Fully Enrolled Second Cohort in Phase 2 Basket Study of WAL0921 In Chronic Kidney DiseasePlans to Initiate Rare Kidney Diseases Cohort in Early ...

Annual health checkups regularly include urine tests that serve several purposes, including checking for symptoms of kidney disease.

Mosliciguat is under clinical development by Bayer and currently in Phase I for Kidney Disease (Nephropathy). According to GlobalData, Phase I drugs for Kidney Disease (Nephropathy) have a 71% phase ...

Diabetic nephropathy is the most common form of chronic kidney disease and a leading cause of renal failure in end-stage renal disease. No currently available treatment can achieve complete cure.

in patients with established Type II diabetic nephropathy, resulted in positive and beneficial results for the majority of patients related to worsening kidney function and disease progression.